Sen. Capito: Senate Republicans - Unprecedented Drug Price Control Scheme Threatens Innovation, Future Drug Costs
September 17, 2022
September 17, 2022
WASHINGTON, Sept. 17 -- Sen. Shelley Moore Capito, R-West Virginia, issued the following news release and letter:
U.S. Senator Shelley Moore Capito (R-W.Va.), along with her Senate Republican colleagues, this week expressed concerns in a letter--led by U.S. Senate Finance Committee Ranking Member Mike Crapo (R-Idaho)--about the establishment of a permanent government price-setting program, funded by billions of taxpayer dollars, in the partisan Inflation Reduction Act. Additionally, . . .
U.S. Senator Shelley Moore Capito (R-W.Va.), along with her Senate Republican colleagues, this week expressed concerns in a letter--led by U.S. Senate Finance Committee Ranking Member Mike Crapo (R-Idaho)--about the establishment of a permanent government price-setting program, funded by billions of taxpayer dollars, in the partisan Inflation Reduction Act. Additionally, . . .
